352 related articles for article (PubMed ID: 26980746)
21. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
Zeng X; Morgenstern R; Nyström AM
Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
[TBL] [Abstract][Full Text] [Related]
22. Reductive responsive micelle overcoming multidrug resistance of breast cancer by co-delivery of DOX and specific antibiotic.
Cui Y; Yang Y; Ma M; Xu Y; Sui J; Li H; Liang J; Sun Y; Fan Y; Zhang X
J Mater Chem B; 2019 Oct; 7(40):6075-6086. PubMed ID: 31389470
[TBL] [Abstract][Full Text] [Related]
23. Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.
Borghese C; Casagrande N; Pivetta E; Colombatti A; Boccellino M; Amler E; Normanno N; Caraglia M; De Rosa G; Aldinucci D
Oncotarget; 2017 Jun; 8(26):42926-42938. PubMed ID: 28477013
[TBL] [Abstract][Full Text] [Related]
24. Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid.
Yoshiyama A; Morii T; Ohtsuka K; Ohnishi H; Tajima T; Aoyagi T; Mochizuki K; Satomi K; Ichimura S
Anticancer Res; 2016 Feb; 36(2):625-31. PubMed ID: 26851017
[TBL] [Abstract][Full Text] [Related]
25. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
26. Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells.
Jiang P; Zhang P; Mukthavaram R; Nomura N; Pingle SC; Teng D; Chien S; Guo F; Kesari S
Oncotarget; 2016 Sep; 7(36):57932-57942. PubMed ID: 27462771
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
28. Macrophages as potential targets for zoledronic acid outside the skeleton-evidence from in vitro and in vivo models.
Rogers TL; Wind N; Hughes R; Nutter F; Brown HK; Vasiliadou I; Ottewell PD; Holen I
Cell Oncol (Dordr); 2013 Dec; 36(6):505-14. PubMed ID: 24177992
[TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid overcomes adriamycin resistance in acute myeloid leukemia cells by promoting apoptosis.
Fan RF; Chen YX; Fang ZG; Guo XY; Lu Y; Liu LL; Xu YC; Liu XF; Lin DJ
Mol Med Rep; 2016 Dec; 14(6):5660-5666. PubMed ID: 27878279
[TBL] [Abstract][Full Text] [Related]
30. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
[TBL] [Abstract][Full Text] [Related]
31. CXCR4-targeted Nanoparticles Reduce Cell Viability, Induce Apoptosis and Inhibit SDF-1α Induced BT-549-Luc Cell Migration In Vitro.
Chittasupho C; Kewsuwan P; Murakami T
Curr Drug Deliv; 2017; 14(8):1060-1070. PubMed ID: 28215173
[TBL] [Abstract][Full Text] [Related]
32. Zoledronic acid prevents the tumor-promoting effects of mesenchymal stem cells via MCP-1 dependent recruitment of macrophages.
Jia XH; Du Y; Mao D; Wang ZL; He ZQ; Qiu JD; Ma XB; Shang WT; Ding D; Tian J
Oncotarget; 2015 Sep; 6(28):26018-28. PubMed ID: 26305552
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
Guo L; Zheng P; Fan H; Wang H; Xu W; Zhou W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935760
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms.
Quinn JE; Brown LG; Zhang J; Keller ET; Vessella RL; Corey E
Prostate Cancer Prostatic Dis; 2005; 8(3):253-9. PubMed ID: 15999121
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule.
Ghebeh H; Lehe C; Barhoush E; Al-Romaih K; Tulbah A; Al-Alwan M; Hendrayani SF; Manogaran P; Alaiya A; Al-Tweigeri T; Aboussekhra A; Dermime S
Breast Cancer Res; 2010; 12(4):R48. PubMed ID: 20626886
[TBL] [Abstract][Full Text] [Related]
36. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
37. Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.
Salaroglio IC; Gazzano E; Abdullrahman A; Mungo E; Castella B; Abd-Elrahman GEFA; Massaia M; Donadelli M; Rubinstein M; Riganti C; Kopecka J
J Exp Clin Cancer Res; 2018 Nov; 37(1):286. PubMed ID: 30482226
[TBL] [Abstract][Full Text] [Related]
38. Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells.
Zhang Z; Lin G; Yan Y; Li X; Hu Y; Wang J; Yin B; Wu Y; Li Z; Yang XP
Oncogene; 2018 Jun; 37(25):3456-3470. PubMed ID: 29559745
[TBL] [Abstract][Full Text] [Related]
39. Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells.
Jeong J; Lee KS; Choi YK; Oh YJ; Lee HD
J Korean Med Sci; 2011 Dec; 26(12):1569-75. PubMed ID: 22147993
[TBL] [Abstract][Full Text] [Related]
40. Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
Inoue S; Arai N; Tomihara K; Takashina M; Hattori Y; Noguchi M
Eur J Pharmacol; 2015 Aug; 761():44-54. PubMed ID: 25934567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]